Hemodynamic Performance In-Vivo of a New Ventricular Assist Device

Shanghai(2005)

Cited 3|Views3
No score
Abstract
Nowadays, circulatory support has become a common practice in medicine and a standard in the treatments of cardio vascular disease (CVD). A new pneumatic ventricular assist device (VAD) has been developed in Mexico City. This paper shows the first results of acute in-vivo trials, intended to verify the new system for providing physiological flows and pressures. Two VADs were implanted to as right (RVAD), left (LVAD) support in a 65 kg pig. The support time was 20 minutes with RVAD, 20 minutes with LVAD and 20 minutes with biventricular (BiVAD). The VAD proved its capability to maintain physiological parameters during the support time. We are satisfied with the results of this trial, and we believe this study will ascertain the first step on the next phase of in-vivo trials
More
Translated text
Key words
cardiovascular system,diseases,haemodynamics,medical control systems,pneumatic control equipment,prosthetics,20 min,65 kg,BiVAD,CVD,biventricular support,cardiovascular disease,circulatory support,hemodynamic performance,implants,physiological flows,physiological pressures,pneumatic ventricular assist device,ventricular assist device,Artificial heart,Biventricular support,Cardiovascular Diseases,Circulatory support,Left support,Mean Arterial Pressure,Right support,VAD,acute in vivo trials,
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined